HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuya Hoshino Selected Research

Restless Legs Syndrome (Restless Legs)

1/2021Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuya Hoshino Research Topics

Disease

1Fibrosis (Cirrhosis)
01/2022
1Restless Legs Syndrome (Restless Legs)
01/2021
1Neoplasms (Cancer)
01/2018
1Ischemia
01/2018
1Acidosis
10/2016
1Vascular System Injuries
09/2008
1Edema (Dropsy)
09/2008
1Hypokalemia
09/2008
1Necrosis
09/2008

Drug/Important Bio-Agent (IBA)

1NADPH Oxidase 2IBA
01/2022
1acetovanillone (apocynin)IBA
01/2022
11- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2018
1PotassiumIBA
09/2008

Therapy/Procedure

1Aftercare (After-Treatment)
10/2016